Medicare Enrolled
Dr. Charles Mouch, M.D.
Interventional Pain Medicine Physician · San Marcos, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mouch from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mouch?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mouch
Dr. Charles Mouch is an interventional pain medicine physician in San Marcos, TX, with 9 years of NPI registration. Based on federal Medicare data, Dr. Mouch performed 2,167 Medicare services across 1,653 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mouch received a total of $52,383 from 27 pharmaceutical and/or device companies across 475 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mouch is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years in practice
▲ Top 44% volume in TX
$52,383 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,167
Medicare services
Top 44% in TX for interventional pain medicine physician
1,653
Unique beneficiaries
$121
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~241 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
317 | $90 | $657 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
207 | $9 | $118 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
135 | $0 | $2 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
116 | $193 | $3,097 |
| Injection, methylprednisolone acetate, 40 mg | 116 | $6 | $57 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
110 | $114 | $850 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
108 | $238 | $2,654 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
105 | $4 | $44 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
88 | $53 | $666 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
86 | $87 | $1,259 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
74 | $149 | $1,726 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
71 | $194 | $1,857 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
71 | $101 | $951 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
65 | $485 | $4,778 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
65 | $260 | $2,672 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
60 | $196 | $2,827 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
56 | $61 | $311 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
49 | $86 | $1,197 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
47 | $207 | $2,016 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
47 | $105 | $1,008 |
| Spinal neurostimulator electrode insertion A procedure to place an electrode array into the spine through the skin. The electrode is used to deliver electrical stimulation to the nervous system. |
42 | $241 | $25,651 |
| Minimally invasive spine decompression, lower spine A minimally invasive procedure to remove bone from the lower spine to relieve pressure on nerve tissue, guided by imaging and accessed through the skin. |
32 | $700 | $9,628 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
27 | $105 | $572 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $66 | $465 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
20 | $153 | $783 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
17 | $44 | $608 |
| Knee nerve block injection with imaging guidance An injection of anesthetic and/or steroid medication into a nerve branch of the knee, performed using imaging guidance to ensure accurate placement. |
13 | $183 | $2,408 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$52,383
Total received (2020-2024)
Avg $10,477/year across 5 years
Top 6% in TX for interventional pain medicine physician
27
Companies
475
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$22,771 (43.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,742 (43.4%)
Scientific / Research
Research funding and grants
$4,563 (8.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,306 (4.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$26,321
2023
$5,853
2022
$9,903
2021
$8,342
2020
$1,965
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Nevro Corp.
$28,255
Medtronic, Inc.
$5,946
PAINTEQ LLC
$4,028
Spinal Simplicity, LLC
$3,352
BOSTON SCIENTIFIC CORPORATION
$2,396
Medtronic USA, Inc.
$1,965
Relievant Medsystems, Inc.
$1,263
Nalu Medical, Inc.
$1,126
SI-BONE, INC.
$1,076
Abbott Laboratories
$951
Vertos Medical, Inc.
$539
SPR Therapeutics, Inc
$395
Boston Scientific Corporation
$170
Bioventus LLC
$145
Stratus Medical, LLC
$116
Averitas Pharma Inc.
$105
Biohaven Pharmaceutical Holding Company Ltd.
$102
BIOTRONIK NRO, Inc.
$84
ABBVIE INC.
$81
Stryker Corporation
$72
Collegium Pharmaceutical, Inc.
$58
Foundation Fusion Solutions, LLC
$44
Pacira Pharmaceuticals Incorporated
$39
Ultragenyx Pharmaceutical Inc.
$23
SI-BONE, Inc.
$22
Scilex Pharmaceuticals Inc.
$15
HydroCision, Inc.
$14
Top 3 companies account for 73.0% of total payments
Associated products mentioned in payments ›
BIOTRONIK · Belbuca · Crysvita · Durolane · ETERNA · GELSYN-3 · GENERAL THERAPIES · GENERAL PAIN MANAGEMENT · General - Pain Management · General - Therapies · HA MINUTEMAN G3-R · IFUSE IMPLANT SYSTEM · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · Iovera · MAKO · NURTEC ODT · Nalu Neurostimulation System · Nimbus · OCTRODE · Omnia · PAINTEQ · PROCLAIM · Proclaim IPG · Prospera · QULIPTA · QUTENZA · SPRINT PNS System · SYNCHROMED · SYNCHROMEDII · Senza · Stimrouter Implantable Kit · Superion · TENJET · UBRELVY · VANTA ADAPTIVESTIM · VENASEAL · Vanta · Vyrsa V1 · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (44%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 6% for interventional pain medicine physician in TX.
Equivalent to $2,417 per 100 Medicare services performed
Geographic Context
Interventional pain medicine physicians within 10 mi
4
Per 100K population
1.6
County median income
$85,827
Nearest hospital
CHRISTUS SANTA ROSA HOSPITAL-SAN MARCOS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mouch is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 6% of TX peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mouch experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mouch performed 317 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mouch receive payments from pharmaceutical companies?
Yes. Dr. Mouch received a total of $52,383 from 27 companies across 475 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mouch's costs compare to other interventional pain medicine physicians in San Marcos?
Dr. Mouch's average Medicare payment per service is $121. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mouch) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in San Marcos
Browse interventional pain medicine physicians in San Marcos ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in TX
Interventional pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in TX
Which TX interventional pain medicine physicians receive the most from drug and device companies.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
PAINTEQ LLC Payments to Doctors
See all physicians who received payments from PAINTEQ LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology